EE663 Societal Impact Analysis of Introducing Elexacaftor Tezacaftor Ivacaftor (ELX TEZ IVA) in the Management of People With Cystic Fibrosis in Germany: A Paid and Unpaid Work Productivity Approach
Abstract
Authors
Conor Daly Foteini Tsotra Gabriel Ghizzi Pedra Malina Müller Gabriela Vega-Hernandez